Molecular Templates Inc (NASDAQ: MTEM) is -79.89% lower on its value in year-to-date trading and has touched a low of $0.29 and a high of $6.48 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The MTEM stock was last observed hovering at around $0.75 in the last trading session, with the day’s loss setting it 0.0%.
Currently trading at $0.75, the stock is -35.09% and -42.79% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.44 million and changing 0.00% at the moment leaves the stock -61.86% off its SMA200. MTEM registered -88.10% loss for a year compared to 6-month loss of -50.00%. The firm has a 50-day simple moving average (SMA 50) of $1.3116 and a 200-day simple moving average (SMA200) of $1.9668.
The stock witnessed a -44.44% gain in the last 1 month and extending the period to 3 months gives it a -44.85%, and is 92.36% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 60.03% over the week and 20.91% over the month.
Molecular Templates Inc (MTEM) has around 62 employees, a market worth around $4.94M and $25.47M in sales. Profit margin for the company is -61.35%. Distance from 52-week low is 154.24% and -88.43% from its 52-week high. The company has generated returns on investments over the last 12 months (-100.81%).
with sales reaching $330k over the same period., but quarterly earnings will post -78.50% year-over-year. Quarterly sales are estimated to shrink -95.10% in year-over-year returns.
Molecular Templates Inc (MTEM) Top Institutional Holders
33.0 institutions hold shares in Molecular Templates Inc (MTEM), with institutional investors hold 58.43% of the company’s shares. The shares outstanding are 6.58M, and float is at 5.44M with Short Float at 2.61%. Institutions hold 56.12% of the Float.
Molecular Templates Inc (MTEM) Insider Activity
The most recent transaction is an insider purchase by BIOTECH TARGET N V, the company’s 10% Owner. SEC filings show that BIOTECH TARGET N V bought 250,000 shares of the company’s common stock on Apr 02 ’24 at a price of $2.35 per share for a total of $0.59 million. Following the purchase, the insider now owns 1.28 million shares.
